News Focus
News Focus
icon url

Horseb4CarT

09/11/22 10:44 PM

#513052 RE: meirluc #513037

Surely not an expert or even close, however I think I remember that tumor load is a factor in OS.

If so, then maybe getting DCVax early after initial resection might have better survival results than after progression of remaining tumor material?
icon url

Doc logic

09/12/22 12:32 PM

#513165 RE: meirluc #513037

meirluc,

When 1:9.5 survive 5 years or more in nGBM 25/232 and 1:10-30 (to be determined) survive to 5 years in rGBM then advantage nGBM. There is a good reason the 17 SOC/placebo were kept out of this trial after the Spring Refresh (blinded data analysis). Best wishes.
icon url

Idunno

09/12/22 12:48 PM

#513168 RE: meirluc #513037

Yeah. Thanks again, meirluc. ‘Interesting’ likely my understatement. The JA, with such expected further data re further survival efficacy, as such, should be quite that. …. And I don’t think LL and or LP have been standing still. Learning, Tweaking. Combos. Patents. Manufacturing Tech. I appreciated your later posting, eloquence…. “Elicitation of immunity….” Anyway. I just wanted to thank you again, after DocL posted. Quite today. …. Best.